Jean-Francois Formela
@jeanfrancoisformela8997
Director
Building Antares Therapeutics, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Antares Therapeutics, Inc. was founded in 2025 and has no closure on record.
Named alongside
- Adam FriedmanExecutive Officer, Director
- Andrew FedderExecutive Officer
- Brian PiperExecutive Officer
- Jeffrey AlbersDirector
- Keith FlahertyDirector
- Menelas N. PangalosDirector
- Shelley ChuDirector
- Gary GlickExecutive Officer, Director
- John LeonardDirector
- Shelley ChuDirector
- Gary GlickExecutive Officer, Director
- John LeonardDirector
- Shelley ChuDirector
- Gary GlickExecutive Officer, Director
- John LeonardDirector
- Shelley ChuDirector
- Gary GlickMr. Glick is a director and the President of the Issuer.
- David BonitaDirector
- Iain D. DukesDirector
- Iain DukesDirector
- Jean-Francois D. FormelaDirector
- Jeffrey EcsedyExecutive Officer
- Jotin MarangoExecutive Officer
- Maria D. KoehlerDirector
- Maria KoehlerDirector
At Intellia Therapeutics, Inc.
- Carl GordonDirector
- John LeonardExecutive Officer, Director
- Jose RiveraExecutive Officer
- Nessan BerminghamExecutive Officer, Director
- Rachel HaurwitzDirector
- Nessan BerminghamExecutive Officer, Director, Promoter
- Ommer ChohanExecutive Officer, Director, Promoter
At Navitor Pharmaceuticals, Inc.
- Alan CraneDirector
- Alan P. CraneDirector
- Barry P. BurgdorfDirector
- Brian GallagherDirector
- Brian P. Gallagher, Ph.D.Director
- David MaddenDirector
- David P. MaddenDirector
- George P. VlasukExecutive Officer, Director
Contribution
Jean-Francois's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Antares Therapeutics, Inc.Director · Biotechnology · BOSTON, United States · Founded 2025
- Intellia Therapeutics, Inc.In Vitro & In Vivo Diagnostic Substances; listed on Nasdaq as NTLA; filing with the SEC since 2015Director · Biotechnology · CAMBRIDGE, United States · Founded 2014
- RaNA Therapeutics, LLCDirector · Biotechnology · CAMBRIDGE, United States · Founded 2012
- Navitor Pharmaceuticals, Inc.formerly Calorics, Inc.; filing with the SEC since 2013Director · Pharmaceuticals · CAMBRIDGE, United States · Founded 2010
- IFM Therapeutics, Inc.Director · Biotechnology · CAMBRIDGE, United States · Founded 2015
- Spero Therapeutics, LLCPharmaceutical Preparations; formerly Spero Therapeutics, LLC; listed on Nasdaq as SPRO; filing with the SEC since 2017Director · Biotechnology · CAMBRIDGE, United States · Founded 2013
- RaNA Therapeutics, Inc.Biological Products, (No Diagnostic Substances); formerly RaNA Therapeutics, Inc.; filing with the SEC since 2017Director · Biotechnology · CAMBRIDGE, United States · Founded 2016
- KORRO BIO, INC.Director · Biotechnology · CAMBRIDGE, United States · Founded 2018
- IFM Continua, Inc.Director · Biotechnology · BOSTON, United States · Founded 2019
- IFM Cinque, Inc.Director · Biotechnology · BOSTON, United States · Founded 2019
- IFM Quattro, Inc.Director · Biotechnology · BOSTON, United States · Founded 2019
- Scorpion Therapeutics, Inc.Pharmaceutical Preparations; filing with the SEC since 2020Director · Biotechnology · BOSTON, United States · Founded 2020
- Ikena Oncology, Inc.Biological Products, (No Diagnostic Substances); formerly Ikena Oncology, Inc.; listed on Nasdaq as IMA; filing with the SEC since 2021Director · Biotechnology · BOSTON, United States